Form 4: Surgery Partners CFO Acquires Shares Following Performance Vesting

David T. Doherty, CFO of Surgery Partners, Inc., acquired 26,784 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Summary

• On January 31, 2025, David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc., acquired 26,784 shares of common stock.
• The acquisition was a result of performance stock unit awards granted on February 1, 2022, that vested based on performance criteria over a three-year period ending December 31, 2024.
• The shares vested immediately upon certification by the Board on January 31, 2025.
• Following the transaction, Doherty directly owns 122,503 shares of Surgery Partners, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of shares indicates that performance targets were met, which is a positive sign. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The vesting of performance stock units suggests that the company met certain performance targets, which is a positive indicator.
• The CFO's increased stake in the company aligns his interests with those of the shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates the CFO's acquisition of shares due to performance-based vesting, which is a common practice in executive compensation.

Comparison to Industry Standards

• Performance-based equity compensation is a standard practice among publicly traded companies to align executive incentives with shareholder value.
• Vesting schedules and performance metrics vary across companies and industries, but the general principle remains the same: executives are rewarded for achieving specific goals that benefit the company and its shareholders.
• Comparing Surgery Partners' performance metrics and vesting schedules to those of its peers (e.g., AmSurg, Envision Healthcare, Tenet Healthcare) would provide a more comprehensive understanding of the competitiveness of its executive compensation practices.

Stakeholder Impact

• Shareholders may view the vesting of performance-based equity as a positive sign, indicating that management is incentivized to achieve company goals.
• Employees may see this as a reflection of the company's performance and a potential indicator of future opportunities.

Key Dates